+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Correlation between thymidylate synthase protein expression and gene polymorphism with clinicopathological parameters in colorectal carcinoma



Correlation between thymidylate synthase protein expression and gene polymorphism with clinicopathological parameters in colorectal carcinoma



International Journal of Surgical Pathology 17(3): 181-186



5-Fluorouracil (5-FU) represents the basis of chemotherapy for colorectal carcinoma, inhibiting thymidylate synthase (TS), an essential enzyme for DNA replication. Previous studies have associated high TS protein expression by tumor cells with poor outcome of patients with colorectal carcinoma, but others have refuted these findings. In view of the potential role of TS as predictive parameter and the lack of consensus in the literature, the present study compared 2 methods: protein expression and gene polymorphism, correlating them with clinicopathological findings. Immunohistochemical detection of TS in tumor cells and detection of gene polymorphism in the blood were performed in 32 patients with colorectal carcinoma treated with 5-FU. No correlation was found between TS protein expression and gene polymorphism. Neither method correlated with survival, tumor staging, and tumor histological grading. This result possibly reflects a complex tumor response to 5-FU therapy, where TS is just one of the involved proteins.

(PDF emailed within 0-6 h: $19.90)

Accession: 052359356

Download citation: RISBibTeXText

PMID: 19147506

DOI: 10.1177/1066896908330480


Related references

Immunohistochemical analysis of thymidylate synthase expression in gastric carcinoma: correlation with clinicopathological parameters and survival. Histology and Histopathology 32(2): 193-201, 2016

Polymorphisms of thymidylate synthase gene and correlation of its protein expression to lymph node metastasis of esophageal squamous cell carcinoma. Ai Zheng 24(10): 1225-1229, 2005

Thymidylate synthase expression and TS gene polymorphism in colorectal cancer Implications on therapeutic response to 5-FU. European Journal of Cancer 37(Supplement 6): S298, 2001

Correlations of clinicopathological factors with protein expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in colorectal cancer. ChemoTherapy 56(2): 120-126, 2010

Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer. Oncology Reports 11(4): 839-843, 2004

Polymorphism of the thymidylate synthase gene and thymidylate synthase levels in colon cancer cell lines and different tissues of colorectal cancer patients. Nucleosides, Nucleotides and Nucleic Acids 23(8-9): 1381-1384, 2004

Correlation between thymidylate synthase gene variants, RNA and protein levels in primary colorectal adenocarcinomas. Journal of International Medical Research 38(2): 484-497, 2010

A novel SNP within the tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and predicts outcome of metastatic colorectal carcinoma treated with 5-fluorouracil. Proceedings of the American Association for Cancer Research Annual Meeting 44: 118, 2003

Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast. Tumour Biology 36(8): 6485-6496, 2015

Expression of thymidylate synthase gene and recurrence of colorectal carcinoma: their relation and clinical significance. Zhonghua Wai Ke Za Zhi 38(10): 781-783, 2002

Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer. World Journal of Gastroenterology 14(4): 617-621, 2008

Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody. Journal of Histochemistry and Cytochemistry 48(6): 755-760, 2000

Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival. Cancer Journal From Scientific American 5(1): 34-40, 1999

Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer. Anticancer Research 22(5): 2805-2809, 2003

Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. Journal of Clinical Oncology 21(5): 815-819, 2003